Record Information |
---|
Version | 2.0 |
---|
Created at | 2024-03-06 08:12:38 UTC |
---|
Updated at | 2024-09-03 04:19:43 UTC |
---|
NP-MRD ID | NP0332593 |
---|
Natural Product DOI | https://doi.org/10.57994/1853 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Compound 8 |
---|
Description | Compound 8 belongs to the class of organic compounds known as unsaturated aliphatic hydrocarbons. These are aliphatic Hydrocarbons that contains one or more unsaturated carbon atoms. These compounds contain one or more double or triple bonds. Compound 8 was first documented in 2024 (PMID: 39247506). Based on a literature review a significant number of articles have been published on Compound 8 (PMID: 39313048) (PMID: 39277390) (PMID: 39269647) (PMID: 39262264) (PMID: 39230932) (PMID: 39229781). |
---|
Structure | CCCC=CCCCCCCCCCCCCCCCCCCCCCCCCCC=CCCC=CCC InChI=1S/C38H72/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h5,7-8,10,13,15H,3-4,6,9,11-12,14,16-38H2,1-2H3 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C30H34O8 |
---|
Average Mass | 522.5940 Da |
---|
Monoisotopic Mass | 522.22537 Da |
---|
IUPAC Name | octatriaconta-3,7,34-triene |
---|
Traditional Name | octatriaconta-3,7,34-triene |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@@]1(CO[C@@H](C2=CC(OC)=C(OCC3=CC=CC=C3)C=C2)[C@]1([H])COC(C)=O)[C@H](O)C1=CC=C(OC)C(OC)=C1 |
---|
InChI Identifier | InChI=1S/C30H34O8/c1-19(31)36-18-24-23(29(32)21-10-12-25(33-2)27(14-21)34-3)17-38-30(24)22-11-13-26(28(15-22)35-4)37-16-20-8-6-5-7-9-20/h5-15,23-24,29-30,32H,16-18H2,1-4H3/t23-,24+,29+,30-/m0/s1 |
---|
InChI Key | GJRLOJNVRCJJQW-JPBZRQQJSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | Not Available | Keio University | Haruhisa Kikuchi | 2024-03-06 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | Not Available | Keio University | Haruhisa Kikuchi | 2024-03-06 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as unsaturated aliphatic hydrocarbons. These are aliphatic Hydrocarbons that contains one or more unsaturated carbon atoms. These compounds contain one or more double or triple bonds. |
---|
Kingdom | Organic compounds |
---|
Super Class | Hydrocarbons |
---|
Class | Unsaturated hydrocarbons |
---|
Sub Class | Unsaturated aliphatic hydrocarbons |
---|
Direct Parent | Unsaturated aliphatic hydrocarbons |
---|
Alternative Parents | |
---|
Substituents | - Unsaturated aliphatic hydrocarbon
- Olefin
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Abd El-Lateef HM, Ezelarab HAA, Ali AM, Alsaggaf AT, Mahdi WA, Alshehri S, El Hamd MA, Aboelez MO: Design and evaluation of sulfadiazine derivatives as potent dual inhibitors of EGFR(WT) and EGFR(T790M): integrating biological, molecular docking, and ADMET analysis. RSC Adv. 2024 Sep 6;14(39):28608-28625. doi: 10.1039/d4ra04165h. eCollection 2024 Sep 4. [PubMed:39247506 ]
- Srikanth D, Shanthi K, Paoletti N, Joshi SV, Shaik MG, Rana P, Vadakattu M, Yaddanapudi VM, Supuran CT, Nanduri S: Exploration of 1,3,5-trisubstituted pyrazoline derivatives as human carbonic anhydrase inhibitors: Synthesis, biological evaluation and in silico studies. Int J Biol Macromol. 2024 Sep 21;280(Pt 3):135890. doi: 10.1016/j.ijbiomac.2024.135890. [PubMed:39313048 ]
- Wang M, Dong L, Wang Y, Suo F, Zhang L, Dong J, Ma S: Validation of shikimate dehydrogenase as the herbicidal target of drupacine and screening of target-based compounds with high herbicidal activity. Pestic Biochem Physiol. 2024 Sep;204:106077. doi: 10.1016/j.pestbp.2024.106077. Epub 2024 Aug 5. [PubMed:39277390 ]
- Danilov R, Smirnova IE, Galimova ZI, Sokolova EV, Lukyanov AV, Kalitin KY, Mukha OY, Babkov D, Kazakova OB, Spasov AA: A Novel Dipterocarpol Derivative that Targets Alpha-Glucosidase and NLRP3 Inflammasome Activity for Treatment of Diabetes Mellitus. Chem Biodivers. 2024 Sep 13:e202401626. doi: 10.1002/cbdv.202401626. [PubMed:39269647 ]
- Banerjee S, Mukherjee S, Mohsin Kazi, Sen KK, Das A, Hasan R, Wu YS, Eftekhari A, Das SK, Nur-E-Alam M, Sarker MMR, Nur Azlina MF: Anti- COVID-19 drug discovery by flavonoid derivatives: an extensive computational drug design approach. Cell Mol Biol (Noisy-le-grand). 2024 Sep 8;70(8):39-49. doi: 10.14715/cmb/2024.70.8.5. [PubMed:39262264 ]
- Wei J, Shi Q, Li B, Yang H, Liu L, Zhou R, Feng Z, Yang Z, Zhan J, Xiong XF, Huang X, Wang Y: Discovery of a Highly Potent and Selective Inhibitor Targeting Protein Lysine Methyltransferase NSD2. J Med Chem. 2024 Sep 26;67(18):16056-16071. doi: 10.1021/acs.jmedchem.4c00639. Epub 2024 Sep 4. [PubMed:39230932 ]
- Aghaei Khouzani M, Noaparast Z, Asadi T, Saeidi S, Heidarnia A, Hamzeh Moghadam B, Mosavi Kia H, Hashemi SM, Mahdavi M: Synthesis, cytotoxicity and (99m)Tc-MIBI tumor cell uptake evaluation of 2-phenylbenzothiazole tagged triazole derivatives. Future Med Chem. 2024;16(19):1999-2012. doi: 10.1080/17568919.2024.2389771. Epub 2024 Sep 4. [PubMed:39229781 ]
- Zhang J, Li S, Zheng Y, Gao L, Wei H, Li Y, Liu Y, Zheng Y, Gong J: Novel pyridazinone derivatives bind to KSRP: Synthesis, anti-tumor biological evaluations and modelling insights. Eur J Med Chem. 2024 Nov 15;278:116811. doi: 10.1016/j.ejmech.2024.116811. Epub 2024 Aug 30. [PubMed:39217859 ]
- Nakane K, Morisseau C, Dowker-Key PD, Benitez G, Aguilan JT, Nagai E, Sidoli S, Hammock BD, Bettaieb A, Shinoda K, Kitamura S: In vivo -Active Soluble Epoxide Hydrolase-targeting PROTACs with Improved Potency and Stability. bioRxiv [Preprint]. 2024 Jul 24:2024.07.23.604814. doi: 10.1101/2024.07.23.604814. [PubMed:39211216 ]
- Vieira TM, Barco JG, de Souza SL, Santos ALO, Daoud I, Rahali S, Amdouni N, Bastos JK, Martins CHG, Ben Said R, Crotti AEM: In Vitro and In Silico Studies of the Antimicrobial Activity of Prenylated Phenylpropanoids of Green Propolis and Their Derivatives against Oral Bacteria. Antibiotics (Basel). 2024 Aug 22;13(8):787. doi: 10.3390/antibiotics13080787. [PubMed:39200088 ]
- Sluga J, Tomasic T, Anderluh M, Rambaher MH, Bajc G, Sevsek A, Martin NI, Pieters RJ, Novic M, Venko K: Targeting N-Acetylglucosaminidase in Staphylococcus aureus with Iminosugar Inhibitors. Antibiotics (Basel). 2024 Aug 10;13(8):751. doi: 10.3390/antibiotics13080751. [PubMed:39200051 ]
- Wu J, Ye J, Cen J, Chen Y, Xu J: Induction of Three New Secondary Metabolites by the Co-Culture of Endophytic Fungi Phomopsis asparagi DHS-48 and Phomopsis sp. DHS-11 Isolated from the Chinese Mangrove Plant Rhizophora mangle. Mar Drugs. 2024 Jul 24;22(8):332. doi: 10.3390/md22080332. [PubMed:39195448 ]
- Tran CV, Tran TTP, Nguyen AT, Tran LV, Pham NT, Nguyen LT, Nguyen DT, Garrett MD, Nguyen NT, Do TT, Serpell CJ, Tran SV: Synthesis and cytotoxic activity of madecassic acid-silybin conjugate compounds in liver cancer cells. RSC Med Chem. 2024 Aug 2;15(10):3418-32. doi: 10.1039/d4md00170b. [PubMed:39185454 ]
- Kaur G, Thakur A, Sharma L, Rani N: Pyridazine Derivatives: Molecular Docking, ADMET Prediction, and Synthesis for Antihypertensive Activity. Cardiovasc Hematol Agents Med Chem. 2024 Aug 19. doi: 10.2174/0118715257316272240807075752. [PubMed:39162284 ]
- Zhang X, Zhang W, Zhao L, Ma G, Huang Y, Geng Z, Jiang Q, Wen X, Lin Y, Meng Q, Zhang Z, Bi Y: Ocotillol Derivatives Mitigate Retinal Ischemia-Reperfusion Injury by Regulating the Keap1/Nrf2/ARE Signaling Pathway. J Med Chem. 2024 Sep 12;67(17):15268-15290. doi: 10.1021/acs.jmedchem.4c00867. Epub 2024 Aug 15. [PubMed:39145589 ]
|
---|